TRIM27/MRTF-B-dependent integrin β1 expression defines leading cells in cancer cell collectives

Cell Reports

Volumn 7, Issue 4, 2014, Pages 1156-1167

  Kato, Takuya ^a   Enomoto, Atsushi ^a   Watanabe, Takashi ^a   Haga, Hisashi ^b,c   Ishida, Sumire ^b   Kondo, Yuji ^a   Furukawa, Koichi ^a   Urano, Takeshi ^d   Mii, Shinji ^a   Weng, Liang ^a   Ishida Takagishi, Maki ^a   Asai, Masato ^a   Asai, Naoya ^a   Kaibuchi, Kozo ^a   Murakumo, Yoshiki ^a,e   Takahashi, Masahide ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d SHIMANE UNIVERSITY   (Japan)

^e KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; HISTONE H2A; MESSENGER RNA; MICRORNA 124; PEPTIDES AND PROTEINS; PROTEIN MRTF B; PROTEIN TRIM27; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; MYOCARDIN-RELATED TRANSCRIPTION FACTOR B, MOUSE; NUCLEAR PROTEIN; TRIM27 PROTEIN, HUMAN; TRIM27 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELLS; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; FOLLOWING CELL; HISTONE UBIQUITINATION; IN VITRO STUDY; IN VIVO STUDY; LEADING CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; TUMOR INVASION; UPREGULATION; CANCER GROWTH; CELL FUNCTION; CELL HETEROGENEITY; CELL SURFACE; COMPLEX FORMATION; GENE EXPRESSION REGULATION; GENETIC STABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; TRANSCRIPTION REGULATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; DISEASE MODEL; GENETICS; HEK293 CELL LINE; METABOLISM; NUDE MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD29; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FEMALE; HEK293 CELLS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84901263566     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.03.068     Document Type: Article

References (75)

1. An J., Enomoto A., Weng L., Kato T., Iwakoshi A., Ushida K., Maeda K., Ishida-Takagishi M., Ishii G., Ming S., et al. Significance of cancer-associated fibroblasts in the regulation of gene expression in the leading cells of invasive lung cancer. J. Cancer Res. Clin. Oncol. 2013, 139:379-388.
2. Bhowmick N.A., Neilson E.G., Moses H.L. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432:332-337.
3. Brandt D.T., Baarlink C., Kitzing T.M., Kremmer E., Ivaska J., Nollau P., Grosse R. SCAI acts as a suppressor of cancer cell invasion through the transcriptional control of beta1-integrin. Nat. Cell Biol. 2009, 11:557-568.
4. Braun S., Madhani H.D. Shaping the landscape: mechanistic consequences of ubiquitin modification of chromatin. EMBO Rep. 2012, 13:619-630.
5. Brockbank E.C., Bridges J., Marshall C.J., Sahai E. Integrin beta1 is required for the invasive behaviour but not proliferation of squamous cell carcinoma cells in vivo. Br. J. Cancer 2005, 92:102-112.
6. Busche S., Descot A., Julien S., Genth H., Posern G. Epithelial cell-cell contacts regulate SRF-mediated transcription via Rac-actin-MAL signalling. J. Cell Sci. 2008, 121:1025-1035.
7. Cao X., Pfaff S.L., Gage F.H. A functional study of miR-124 in the developing neural tube. Genes Dev. 2007, 21:531-536.
8. Carmona-Fontaine C., Matthews H.K., Kuriyama S., Moreno M., Dunn G.A., Parsons M., Stern C.D., Mayor R. Contact inhibition of locomotion in vivo controls neural crest directional migration. Nature 2008, 456:957-961.
9. Charbonney E., Speight P., Masszi A., Nakano H., Kapus A. β-catenin and Smad3 regulate the activity and stability of myocardin-related transcription factor during epithelial-myofibroblast transition. Mol. Biol. Cell 2011, 22:4472-4485.
10. Chi P., Allis C.D., Wang G.G. Covalent histone modifications-miswritten, misinterpreted and mis-erased in human cancers. Nat. Rev. Cancer 2010, 10:457-469.
11. Chu Y., Yang X. SUMO E3 ligase activity of TRIM proteins. Oncogene 2011, 30:1108-1116.
12. DiCostanzo D., Rosen P.P., Gareen I., Franklin S., Lesser M. Prognosis in infiltrating lobular carcinoma. An analysis of "classical" and variant tumors. Am. J. Surg. Pathol. 1990, 14:12-23.
13. Easty D.M., Easty G.C. Measurement of the ability of cells to infiltrate normal tissues in vitro. Br. J. Cancer 1974, 29:36-49.
14. Fan L., Sebe A., Péterfi Z., Masszi A., Thirone A.C., Rotstein O.D., Nakano H., McCulloch C.A., Szászi K., Mucsi I., Kapus A. Cell contact-dependent regulation of epithelial-myofibroblast transition via the rho-rho kinase-phospho-myosin pathway. Mol. Biol. Cell 2007, 18:1083-1097.
15. Farooqui R., Fenteany G. Multiple rows of cells behind an epithelial wound edge extend cryptic lamellipodia to collectively drive cell-sheet movement. J. Cell Sci. 2005, 118:51-63.
16. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat. Rev. Genet. 2008, 9:102-114.
17. Friedl P., Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 2011, 147:992-1009.
18. Friedl P., Gilmour D. Collective cell migration in morphogenesis, regeneration and cancer. Nat. Rev. Mol. Cell Biol. 2009, 10:445-457.
19. Friedl P., Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 2003, 3:362-374.
20. Friedl P., Hegerfeldt Y., Tusch M. Collective cell migration in morphogenesis and cancer. Int. J. Dev. Biol. 2004, 48:441-449.
21. Friedl P., Locker J., Sahai E., Segall J.E. Classifying collective cancer cell invasion. Nat. Cell Biol. 2012, 14:777-783.
22. Gaggioli C., Hooper S., Hidalgo-Carcedo C., Grosse R., Marshall J.F., Harrington K., Sahai E. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat. Cell Biol. 2007, 9:1392-1400.
23. Giampieri S., Manning C., Hooper S., Jones L., Hill C.S., Sahai E. Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat. Cell Biol. 2009, 11:1287-1296.
24. Gillot I., Matthews C., Puel D., Vidal F., Lopez P. Ret finger protein: an E3 ubiquitin ligase juxtaposed to the XY body in meiosis. Int. J. Cell Biol. 2009, 2009:524858.
25. Gov N.S. Collective cell migration patterns: follow the leader. Proc. Natl. Acad. Sci. USA 2007, 104:15970-15971.
26. Graff J.R., Herman J.G., Lapidus R.G., Chopra H., Xu R., Jarrard D.F., Isaacs W.B., Pitha P.M., Davidson N.E., Baylin S.B. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res. 1995, 55:5195-5199.
27. Gray R.S., Cheung K.J., Ewald A.J. Cellular mechanisms regulating epithelial morphogenesis and cancer invasion. Curr. Opin. Cell Biol. 2010, 22:640-650.
28. Hall A. The cytoskeleton and cancer. Cancer Metastasis Rev. 2009, 28:5-14.
29. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
30. Hart I.R. New evidence for tumour embolism as a mode of metastasis. J. Pathol. 2009, 219:275-276.
31. Hegerfeldt Y., Tusch M., Bröcker E.B., Friedl P. Collective cell movement in primary melanoma explants: plasticity of cell-cell interaction, beta1-integrin function, and migration strategies. Cancer Res. 2002, 62:2125-2130.
32. Hidalgo-Carcedo C., Hooper S., Chaudhry S.I., Williamson P., Harrington K., Leitinger B., Sahai E. Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6. Nat. Cell Biol. 2011, 13:49-58.
33. Hou J.M., Krebs M., Ward T., Sloane R., Priest L., Hughes A., Clack G., Ranson M., Blackhall F., Dive C. Circulating tumor cells as a window on metastasis biology in lung cancer. Am. J. Pathol. 2011, 178:989-996.
34. Hunt S., Jones A.V., Hinsley E.E., Whawell S.A., Lambert D.W. MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1. FEBS Lett. 2011, 585:187-192.
35. Iwakoshi A., Murakumo Y., Kato T., Kitamura A., Mii S., Saito S., Yatabe Y., Takahashi M. RET finger protein expression is associated with prognosis in lung cancer with epidermal growth factor receptor mutations. Pathol. Int. 2012, 62:324-330.
36. Kamata K., Hatanaka A., Goswami G., Shinmyozu K., Nakayama J., Urano T., Hatashita M., Uchida H., Oki M. C-terminus of the Sgf73 subunit of SAGA and SLIK is important for retention in the larger complex and for heterochromatin boundary function. Genes Cells 2013, 18:823-837.
37. Kato T., Shimono Y., Hasegawa M., Jijiwa M., Enomoto A., Asai N., Murakumo Y., Takahashi M. Characterization of the HDAC1 complex that regulates the sensitivity of cancer cells to oxidative stress. Cancer Res. 2009, 69:3597-3604.
38. Kolega J. The movement of cell clusters in vitro: morphology and directionality. J. Cell Sci. 1981, 49:15-32.
39. Kreso A., O'Brien C.A., van Galen P., Gan O.I., Notta F., Brown A.M., Ng K., Ma J., Wienholds E., Dunant C., et al. Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer. Science 2013, 339:543-548.
40. Li X., Ishihara S., Yasuda M., Nishioka T., Mizutani T., Ishikawa M., Kawabata K., Shirato H., Haga H. Lung cancer cells that survive ionizing radiation show increased integrin α2β1- and EGFR-dependent invasiveness. PLoS ONE 2013, 8:e70905.
41. Marusyk A., Almendro V., Polyak K. Intra-tumour heterogeneity: a looking glass for cancer?. Nat. Rev. Cancer 2012, 12:323-334.
42. Mayor R., Carmona-Fontaine C. Keeping in touch with contact inhibition of locomotion. Trends Cell Biol. 2010, 20:319-328.
43. McLennan R., Dyson L., Prather K.W., Morrison J.A., Baker R.E., Maini P.K., Kulesa P.M. Multiscale mechanisms of cell migration during development: theory and experiment. Development 2012, 139:2935-2944.
44. Miralles F., Posern G., Zaromytidou A.I., Treisman R. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 2003, 113:329-342.
45. Niepel M., Spencer S.L., Sorger P.K. Non-genetic cell-to-cell variability and the consequences for pharmacology. Curr. Opin. Chem. Biol. 2009, 13:556-561.
46. Olson E.N., Nordheim A. Linking actin dynamics and gene transcription to drive cellular motile functions. Nat. Rev. Mol. Cell Biol. 2010, 11:353-365.
47. Posern G., Treisman R. Actin' together: serum response factor, its cofactors and the link to signal transduction. Trends Cell Biol. 2006, 16:588-596.
48. Reffay M., Parrini M.C., Cochet-Escartin O., Ladoux B., Buguin A., Coscoy S., Amblard F., Camonis J., Silberzan P. Interplay of RhoA and mechanical forces in collective cell migration driven by leader cells. Nat. Cell Biol. 2014, 16:217-223.
49. Ridley A.J., Schwartz M.A., Burridge K., Firtel R.A., Ginsberg M.H., Borisy G., Parsons J.T., Horwitz A.R. Cell migration: integrating signals from front to back. Science 2003, 302:1704-1709.
50. Roesch A., Fukunaga-Kalabis M., Schmidt E.C., Zabierowski S.E., Brafford P.A., Vultur A., Basu D., Gimotty P., Vogt T., Herlyn M. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 2010, 141:583-594.
51. Rørth P. Fellow travellers: emergent properties of collective cell migration. EMBO Rep. 2012, 13:984-991.
52. Sahai E. Mechanisms of cancer cell invasion. Curr. Opin. Genet. Dev. 2005, 15:87-96.
53. Sahai E. Illuminating the metastatic process. Nat. Rev. Cancer 2007, 7:737-749.
54. Sanz-Moreno V., Gadea G., Ahn J., Paterson H., Marra P., Pinner S., Sahai E., Marshall C.J. Rac activation and inactivation control plasticity of tumor cell movement. Cell 2008, 135:510-523.
55. Scheel C., Weinberg R.A. Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin. Cancer Biol. 2012, 22:396-403.
56. Selvaraj A., Prywes R. Megakaryoblastic leukemia-1/2, a transcriptional co-activator of serum response factor, is required for skeletal myogenic differentiation. J. Biol. Chem. 2003, 278:41977-41987.
57. Sharma S.V., Lee D.Y., Li B., Quinlan M.P., Takahashi F., Maheswaran S., McDermott U., Azizian N., Zou L., Fischbach M.A., et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 2010, 141:69-80.
58. Shiio Y., Eisenman R.N. Histone sumoylation is associated with transcriptional repression. Proc. Natl. Acad. Sci. USA 2003, 100:13225-13230.
59. Shimono Y., Murakami H., Hasegawa Y., Takahashi M. RET finger protein is a transcriptional repressor and interacts with enhancer of polycomb that has dual transcriptional functions. J. Biol. Chem. 2000, 275:39411-39419.
60. Spencer S.L., Gaudet S., Albeck J.G., Burke J.M., Sorger P.K. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 2009, 459:428-432.
61. Swanton C. Intratumor heterogeneity: evolution through space and time. Cancer Res. 2012, 72:4875-4882.
62. Takahashi M., Inaguma Y., Hiai H., Hirose F. Developmentally regulated expression of a human "finger"-containing gene encoded by the 5' half of the ret transforming gene. Mol. Cell. Biol. 1988, 8:1853-1856.
63. Tambe D.T., Hardin C.C., Angelini T.E., Rajendran K., Park C.Y., Serra-Picamal X., Zhou E.H., Zaman M.H., Butler J.P., Weitz D.A., et al. Collective cell guidance by cooperative intercellular forces. Nat. Mater. 2011, 10:469-475.
64. Tarin D., Thompson E.W., Newgreen D.F. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res. 2005, 65:5996-6000. discussion 6000-6001.
65. Theveneau E., Mayor R. Cadherins in collective cell migration of mesenchymal cells. Curr. Opin. Cell Biol. 2012, 24:677-684.
66. Theveneau E., Marchant L., Kuriyama S., Gull M., Moepps B., Parsons M., Mayor R. Collective chemotaxis requires contact-dependent cell polarity. Dev. Cell 2010, 19:39-53.
67. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2:442-454.
68. Trepat X., Wasserman M.R., Angelini T.E., Millet E., Weitz D.A., Butler J.P., Fredberg J.J. Physical forces during collective cell migration. Nat. Phys. 2009, 5:426-430.
69. Tsukamoto H., Kato T., Enomoto A., Nakamura N., Shimono Y., Jijiwa M., Asai N., Murakumo Y., Shibata K., Kikkawa F., Takahashi M. Expression of Ret finger protein correlates with outcomes in endometrial cancer. Cancer Sci. 2009, 100:1895-1901.
70. Vaughan R.B., Trinkaus J.P. Movements of epithelial cell sheets in vitro. J. Cell Sci. 1966, 1:407-413.
71. Vignjevic D., Schoumacher M., Gavert N., Janssen K.P., Jih G., Laé M., Louvard D., Ben-Ze'ev A., Robine S. Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res. 2007, 67:6844-6853.
72. Wang H., Wang L., Erdjument-Bromage H., Vidal M., Tempst P., Jones R.S., Zhang Y. Role of histone H2A ubiquitination in Polycomb silencing. Nature 2004, 431:873-878.
73. Wicki A., Lehembre F., Wick N., Hantusch B., Kerjaschki D., Christofori G. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 2006, 9:261-272.
74. Yamamoto E., Kohama G., Sunakawa H., Iwai M., Hiratsuka H. Mode of invasion, bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity. Cancer 1983, 51:2175-2180.
75. Zhou W., Wang X., Rosenfeld M.G. Histone H2A ubiquitination in transcriptional regulation and DNA damage repair. Int. J. Biochem. Cell Biol. 2009, 41:12-15.